Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | 0.00% | +5.26% | -79.49% |
28/03 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
28/03 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
Sales 2022 | 10.88 907.49 | Sales 2023 | 19.59 1.63K | Capitalization | 4.9M 408M |
---|---|---|---|---|---|
Net income 2022 | -25M -2.08B | Net income 2023 | -14M -1.17B | EV / Sales 2022 | 5,68,219 x |
Net cash position 2022 | 3.04M 253M | Net cash position 2023 | 385K 32.1M | EV / Sales 2023 | 2,30,324 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.29
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.56% |
Latest transcript on Agile Therapeutics, Inc.
1 week | +5.26% | ||
Current month | +17.65% | ||
1 month | +8.11% | ||
3 months | -74.68% | ||
6 months | -77.14% | ||
Current year | -79.49% |
Managers | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 01/04/01 |
Scott Coiante
DFI | Director of Finance/CFO | 57 | 01/10/01 |
Paul Korner
CTO | Chief Tech/Sci/R&D Officer | 58 | 17/20/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 01/04/01 |
Seth Fischer
BRD | Director/Board Member | 68 | 28/16/28 |
John Hubbard
BRD | Director/Board Member | 67 | 18/14/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.4 | 0.00% | 28,123 |
25/24/25 | 0.4 | -0.07% | 85,721 |
24/24/24 | 0.4003 | +8.19% | 73,534 |
23/24/23 | 0.37 | -6.09% | 94,553 |
22/24/22 | 0.394 | +3.68% | 15,937 |
Delayed Quote OTC Markets, April 27, 2024 at 12:29 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-79.49% | 2.74M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AGRX Stock